{"page":"https://casescribe.ai/explorer/regulation-changes/2022-10-10","generated_at":"2026-10-03T18:33:41.348Z","data_as_of":{"decisions":944125,"first_year":2017,"last_year":2026,"latest_decision":"2026-04-30","cfr":"2026-10-01","m21":"2026-09-29"},"about":{"publisher":"CaseScribe AI (VA Law Explorer)","source":"Public Board of Veterans' Appeals decisions (appeals of VA decisions, not VA's first decisions), M21-1 Adjudication Procedures Manual, 38 CFR Parts 3 and 4.","method":"Outcomes are issue-level: each condition the Board decided in a decision counts once. Decision data is extracted by AI and can contain errors. Rates describe past appeals and do not predict any claim.","disclaimer":"For research only. CaseScribe AI is not a law firm and this is not legal advice. Verify figures against the source decisions and regulations.","attribution":"Cite as: VA Law Explorer, CaseScribe AI, with the page URL."},"data":{"week_of":"2022-10-10","changes":[{"source":"38 CFR","section":"Schedule of ratings - hemic and lymphatic systems.","date":"2022-10-11","url":"https://www.ecfr.gov/current/title-38/section-4.117","formatting_only":false,"added":["Requiring either continuous myelosuppressive therapy, or, for six months following hospital admission for any of the following treatments:","peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment | 100","If the condition undergoes leukemic transformation, evaluate as leukemia under diagnostic code 7703.","or during the period of treatment with chemotherapy (including myelosuppressants) or interferon treatment.","Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter.","1, 2018;","87 FR 61248, Oct.","11, 2022]"],"removed":["Requiring either continuous myelosuppressive therapy or, for six months following hospital admission, peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment | 100","If the condition undergoes leukemic transformation, evaluate as leukemia under diagnostic code 7703","or during the period of treatment with chemotherapy (including myelosuppressants).","Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter","1, 2018]"]}]}}